Provenienza dei contatti di primo grado di Philip Roberts
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Biotechnology | 22 | |
| Public Company | Biotechnology | 15 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Philip Roberts tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Chief Tech/Sci/R&D Officer | |
Hexion, Inc.
 Hexion, Inc. Industrial SpecialtiesProcess Industries Hexion, Inc. engages in the manufacture of thermoset resins. Its products are used in several applications including abrasives, adhesives, chemical intermediates, civil engineering, coatings, composites, crop protection, electrical/electronics, engineered wood, fertilizers and pesticides, fibers and textiles, foams, friction materials, furniture, molding compounds, oilfield, oriented strand board, particleboard and fiberboard, plywood, and laminated veneer lumber, and refractories. The company was founded in 1899 and is headquartered in Columbus, OH. | Industrial Specialties | Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Human Resources Officer Director of Finance/CFO Corporate Officer/Principal | |
Novartis International AG
 Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
TARIS BioMedical LLC
 TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
| Blackburn College | College/University | Undergraduate Degree | |
| Indiana University | College/University | Undergraduate Degree Doctorate Degree | |
| The University of Chicago | College/University | Masters Business Admin Doctorate Degree Undergraduate Degree | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree Doctorate Degree | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
CovX Research LLC
 CovX Research LLC BiotechnologyHealth Technology Part of Pfizer Inc., CovX Research LLC is a company that manufactures biotherapeutics and medical products. The company is based in San Diego, CA. The company was founded by Richard Alan Lerner, Carlos F. Barbas. CovX Research was acquired by Pfizer Inc. from Tavistock Life Sciences Co. on January 31, 2008 for $230 million. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Cyanco Holding Corp.
 Cyanco Holding Corp. Chemicals: SpecialtyProcess Industries Cyanco Holding Corp. supplies products to the mining industries. The company was founded in 2008 and is headquartered in Reno, NV. | Chemicals: Specialty | Chief Executive Officer | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| Coopers & Lybrand Consulting, Inc. | Corporate Officer/Principal Corporate Officer/Principal | ||
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Signa Chemistry
 Signa Chemistry Metal FabricationProducer Manufacturing Signa Chemistry develops stabilized reactive metals. | Metal Fabrication | Founder | |
Cyanco Corp.
 Cyanco Corp. Industrial SpecialtiesProcess Industries Cyanco Corp. supplies commercial mining explosives. It offers liquid and solid sodium cyanide. The firm offers its products to gold mines. The company was founded in 1988 and is headquartered in Reno, NV. | Industrial Specialties | President | |
| UNIQURE N.V. | Biotechnology | Chairman | |
Cyanco International LLC
 Cyanco International LLC Chemicals: SpecialtyProcess Industries Cyanco International LLC engages in mining solid sodium cyanide. The company is headquartered in Pearland, TX. | Chemicals: Specialty | Chief Executive Officer | |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact Corporate Officer/Principal | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chairman | |
| FUSN PHAR | Pharmaceuticals: Major | Director/Board Member | |
Nucleus Biologics LLC
 Nucleus Biologics LLC BiotechnologyHealth Technology Nucleus Biologics LLC develops cellular immunotherapies. Its products include PhysiologixTM XF SR, Vitronectin XF, Australia and New Zealand Origin FBS and zIsletTM media. The firm offers complete media manufacturing services. The company was founded in 2016 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Stargazer Pharmaceuticals, Inc.
 Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Stargazer Pharmaceuticals, Inc. manufactures pharmaceutical products. The firm engages in the development of treatment for Stargardt’s disease, a rare form of juvenile, retinal degeneration. The company was founded by Gary Jay Sternberg and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Chairman | |
Research Bridge Partners /Venture Capital/
 Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners (Research Bridge Partners) is a venture capital firm founded in 2016 by Reid Hoffman. The firm is headquartered in Austin, Texas. | Investment Managers | Chief Executive Officer Corporate Officer/Principal | |
FerGene, Inc.
 FerGene, Inc. BiotechnologyHealth Technology FerGene, Inc. provides gene therapy solutions to urologists. The company is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
Just Another Acquisition Corp.
 Just Another Acquisition Corp. Financial ConglomeratesFinance Just Another Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York, NY. | Financial Conglomerates | Director/Board Member | |
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Founder Director of Finance/CFO Chief Operating Officer | |
Rocket Global Acquisition Corp.
 Rocket Global Acquisition Corp. Financial ConglomeratesFinance Rocket Global Acquisition Corp. operates as a blank check company. The firm was formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated on February 9, 2021 and is headquartered in New York, NY. | Financial Conglomerates | Director/Board Member | |
| Camping & Education Foundation | Director/Board Member | ||
Hydrobuilder Holdings LLC
 Hydrobuilder Holdings LLC Internet Software/ServicesTechnology Services Hydrobuilder Holdings LLC is a leading omnichannel platform in the hydroponics, CEA, and specialty agriculture industry. The private company is based in the United States, with a retail footprint in four states and commercial warehouse direct capabilities in 17 states. The American company serves a wide range of customers, from hobbyists to large commercial growers, through its online, retail, and warehouse direct channels. These companies include Greencoast, Hydrobuilder.com, Elevated Equipment and Supply, and Way to Grow. Hydrobuilder Holdings was founded in October 2020 and has acquired four market-leading companies across different sales channels and geographies. The CEO of Hydrobuilder Holdings is Markus Alan Hockenson. | Internet Software/Services | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 46 |
| Svizzera | 2 |
| Belgio | 2 |
| Paesi Bassi | 2 |
| Regno Unito | 2 |
Settori
| Health Technology | 31 |
| Consumer Services | 7 |
| Process Industries | 5 |
| Finance | 5 |
| Commercial Services | 3 |
Posizioni
| Director/Board Member | 166 |
| Corporate Officer/Principal | 76 |
| Independent Dir/Board Member | 64 |
| President | 51 |
| Chairman | 47 |
Contatti più connessi
| Insiders | |
|---|---|
| Julie Cherrington | 32 |
| Michael Grey | 32 |
| Faheem Hasnain | 27 |
| Jean-Jacques Bienaimé | 22 |
| Rapp Rapoport | 20 |
| John LaMattina | 20 |
| David Meek | 19 |
| Clay Siegall | 18 |
| Shalini Sharp | 17 |
| Chris LeMasters | 15 |
| Isaac Barchas | 14 |
| Richard Baron | 13 |
| Laurie Stelzer | 13 |
| Joseph Leveque | 12 |
| Michael Lefenfeld | 12 |
- Borsa valori
- Insiders
- Philip Roberts
- Connessioni Società
